Humboldt — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

Examediexamedi.cl in 𝕏Series B · May 2022

Examedi provides at-home blood tests and telemedicine consultations available 24/7 in Chile.

Digital HealthHealthtechMarketplacesSantiago, CL

Andres Kemeny(Founder)in Juan Pablo Zepeda(Founder)inEun Bin Lee(Director)

Co-investorsGeneral Catalyst Y Combinator FJ Labs Nexus Venture Partners Platanus Ventures

Haya Therapeuticshayatx.com in 𝕏Seed · Feb 2022 · $5M

HAYA Therapeutics develops precision RNA medicines that target long non-coding RNAs (lncRNAs) in the regulatory genome to reprogram disease at the level of cell state, with a lead program in cardiac fibrosis and work in obesity and metabolic disease.

AI & Machine LearningBiotechDeep TechHealthtech

Samir Ounzain(Chief Executive Officer (CEO) & Co-founder)inDaniel Blessing(Chief Scientific Officer (CSO) & Co-founder)in Richard Law(Chief Business Officer (CBO))in Eric Adam(Chief Operating Officer (COO))inJordan Shin(Chief Medical Officer (CMO))inJérôme Andries(Chief Financial Officer (CFO))in

Co-investorsBroadview Ventures Sofinnova Partners Apollo Health Ventures +ND Capital 4see Ventures Lifelink

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.